Log In
Print
BCIQ
Print
Print this Print this
 

FoundationOne

Also known as: FoundationOne genomic profile

  Manage Alerts
Collapse Summary General Information
Company Foundation Medicine Inc.
DescriptionLaboratory-developed test (LDT) that identifies all somatically altered genes that are validated targets for therapy or drivers of oncogenesis
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsProfile genomic alterations in solid tumors
Regulatory Designation
Partner Laboratorios LETI

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$1,000.0M

$780.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today